StonvexLoading…
StonvexStonvexStonvexCore line items from FIVN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $305.32M | $1.15B | $285.83M | $283.27M |
Operating Income | $18.49M | $28.85M | $16.04M | $-1.56M |
Net Income | $18.41M | $39.42M | $17.97M | $1.15M |
EPS (Diluted) | $0.21 | $0.45 | $0.21 | $0.01 |
Total Assets | $1.87B | $1.79B | $1.77B | $1.70B |
Total Liabilities | $1.04B | $1.00B | $993.12M | $987.48M |
Cash & Equivalents | $273.01M | $232.08M | $193.41M | $205.48M |
Free Cash Flow OCF − CapEx | $58.65M | $201.24M | $123.92M | $75.23M |
Shares Outstanding | 76.56M | 77.19M | 78.21M | 77.26M |